Upgrade to SI Premium - Free Trial

CORRECTING and REPLACING -- Determine Announces 4th Quarter and Fiscal Year 2018 Financial Results

June 26, 2018 5:30 PM

CARMEL, Ind., June 26, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Determine, Inc., the financial tables were omitted. The complete and corrected press release follows:

Determine, Inc. (NASDAQ: DTRM), a pioneering leader in global Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) Cloud Platform solutions, announces financial results for its fourth quarter and fiscal year ended March 31, 2018.

FY2018 GAAP Financial Highlights:

(in thousands, except per share amounts)
GAAP Financial Measures Q4Q3Q4ChangeChangeTwelve Months
FY 2018FY 2018FY 2017 Q/Q Y/YFY 2018FY 2017Change Y/Y
Revenue - total$ 6,776 $ 7,467 $ 7,535 (9.3%) (10.1%)$ 28,119 $ 27,463 2.4%
Revenue - recurring$ 5,467 $ 5,552 $ 5,628 (1.5%) (2.9%)$ 21,864 $ 20,895 4.6%
Revenue - non-recurring$ 1,309 $ 1,915 $ 1,907 (31.6%) (31.4%)$ 6,255 $ 6,568 (4.8%)
Gross profit - total$ 3,344 $ 4,160 $ 3,973 (19.6%) (15.8%)$ 14,621 $ 13,838 5.7%
Gross profit - recurring$ 3,378 $ 3,649 $ 3,696 (7.4%) (8.6%)$ 13,912 $ 13,878 0.2%
Gross profit (loss) - non-recurring$ (34)$ 511 $ 277 (106.7%) (112.3%)$ 709 $ (40) 1872.5%
Gross margin - total 49.4% 55.7% 52.7%(6.3 pts)(3.3 pts) 52.0% 50.4%1.6 pts
Gross margin - recurring 61.8% 65.7% 65.7%(3.9 pts)(3.9 pts) 63.6% 66.4%(2.8 pts)
Gross margin - non recurring (2.6%) 26.7% 14.5%(29.3 pts)(17.1 pts) 11.3% (0.6%)11.9 pts
Net loss$ (2,822)$ (2,346)$ (1,708) 20.3% 65.2%$ (9,948)$ (9,452) 5.2%
EPS$ (0.19)$ (0.16)$ (0.14)$ (0.03)$ (0.05)$ (0.69)$ (0.81)$ 0.12

FY2018 Non-GAAP Financial Highlights:

(in thousands, except per share amounts)
Non-GAAP Financial Measures Q4Q3Q4ChangeChangeTwelve Months
FY 2018 FY 2018 FY 2017 Q/Q Y/YFY 2018FY 2017Change Y/Y
Revenue - total$ 6,776 $ 7,467 $ 7,535 (9.3%) (10.1%)$ 28,119 $ 27,471 2.4%
Revenue - recurring$ 5,467 $ 5,552 $ 5,628 (1.5%) (2.9%)$ 21,864 $ 20,903 4.6%
Revenue - non-recurring$ 1,309 $ 1,915 $ 1,907 (31.6%) (31.4%)$ 6,255 $ 6,568 (4.8%)
Gross profit - total$ 3,626 $ 4,484 $ 4,297 (19.1%) (15.6%)$ 15,897 $ 15,192 4.6%
Gross profit - recurring$ 3,646 $ 3,916 $ 3,967 (6.9%) (8.1%)$ 15,051 $ 15,004 0.3%
Gross profit ( loss) - non-recurring$ (21)$ 568 $ 330 (103.6%) (106.2%)$ 846 $ 188 350.0%
Gross margin - total 53.5% 60.1% 57.0%(6.6 pts)(3.5 pts) 56.5% 55.3%1.2 pts
Gross margin - recurring 66.7% 70.5% 70.5%(3.8 pts)(3.8 pts) 68.8% 71.8%(3.0 pts)
Gross margin - non recurring (1.5%) 29.7% 17.3%(31.2 pts)(18.8 pts) 13.5% 2.9%10.6 pts
Net loss$ (1,726)$ (1,303)$ (428) 32.5% 303.3%$ (5,487)$ (4,681) 17.2%
EPS$ (0.12)$ (0.09)$ (0.04)$ (0.03)$ (0.08)$ (0.38)$ (0.40)$ 0.02
Billings$ 5,991 $ 8,856 $ 7,582 (32.4%) (21.0%)$ 27,610 $ 27,177 1.6%

“I would sum up fiscal 2018 under the theme of ‘Doubling Down.’ We have done this in all areas of the company this past year, from our continued investment in and expansion of the capabilities on the Determine Cloud Platform, to key appointments of seasoned, industry experts on the leadership team and board, and to an even deeper focus on customer success and advocacy. These efforts are illustrated by our many advancements including the launch of our HIPAA compliance program which demonstrates our ongoing commitment to our valued – and growing - healthcare customers. We further expanded advanced capabilities across the entire modular Source-to-Pay and Contract Management continuum, often in collaboration with customer users. During Fiscal 2018, we seized the opportunity to bolster key positions within our Sales & Marketing, Partnership Management and Customer Success groups with veteran industry-recognized talent. These subject matter experts are critical to supporting our efforts to achieve our pipeline and customer success goals. Concurrently, we’ve formalized a company-wide program with the goal of improving overall satisfaction and converting customers into advocates. These efforts are resulting in significant customer-directed product innovation as well as creating additional sales and upsell opportunities. As I noted previously, our goal is to exceed expectations at every stage ­– especially those of our customers. We are redoubling our efforts as we move confidently down that path.”— Patrick Stakenas, President, CEO and Director, Determine, Inc.

FY2018 Determine Business Highlights:

Conference Call and Webcast Tuesday, June 26, 2018 at 5:00 PM (Eastern Time)

Participant Conference Call Numbers:
Toll-Free: 1-877-407-0789
Toll/International:1-201-689-8562
Participant Webcast Link:http://public.viavid.com/index.php?id=130010
Replay Dial-in Information:
Toll-Free: 1-844-512-2921
Toll/International: 1-412-317-6671
From: 06/26/18 at 8:00 pm Eastern Time
To: 07/03/18 at 11:59 pm Eastern Time
Replay Pin Number: 13680590

Related: http://investor.determine.com

Non-GAAP Financial Measures

To supplement our financial results presented in accordance with Generally Accepted Accounting Principles (GAAP), this press release and the accompanying tables contain certain non-GAAP financial measures, including non-GAAP revenue, non-GAAP gross profit, non-GAAP net income and non-GAAP earnings per share, which we believe are helpful in understanding our past financial performance and future results. For reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures, please see the section of the accompanying tables titled, “GAAP to Non-GAAP Reconciliations”. Our non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The difference between GAAP and non-GAAP revenue is due to the impact of revaluing the deferred revenue balances acquired from primarily b-pack as required by GAAP purchase accounting.

The difference between GAAP and non-GAAP gross profit is the difference in GAAP versus non-GAAP revenues as well as the elimination of the amortization of acquisition related intangibles, stock based compensation and severance expense from the costs of revenue. Non-GAAP net loss excludes the non-GAAP gross profit items as well as acquisition related costs.

Our management regularly uses our supplemental non-GAAP financial measures internally to understand and manage our business and forecast future periods; as such, we believe it is useful for investors to understand the effects of these items on our total operations. Further, please note that our non-GAAP revenue is intended to reflect the full amount of revenues that would have been otherwise recorded by the acquired entities of Iasta and b-pack, while our non-GAAP gross profit also excludes the amortization of intangibles that occurred due to the acquisition of the entities of Iasta and b-pack.

Annualized Bookings are an operating measure not derived from the company’s revenues or any other amounts presented in accordance with GAAP in the company’s statement of income, balance sheet or statement of cash flows or other equivalent statements.

Forward-looking Statements

Certain statements in this release and elsewhere by Determine are forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements regarding business outlook, assessment of market conditions, anticipated financial and operating results, strategies, product and channel development, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward-looking statements include, but are not limited to fluctuations in demand for Determine’s products and services, risks of losing key personnel or customers, protection of the company’s intellectual property and government policies and regulations, including, but not limited to those affecting the company’s industry. Determine undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional risk factors concerning the company can be found in the company’s most recent Form 10-K as filed by the company with the Securities and Exchange Commission.

Supporting Resources

Determine Blog

Determine on LinkedIn

Determine on Twitter

Determine Resources

About Determine, Inc.

Determine, Inc. (NASDAQ: DTRM) is a leading global provider of SaaS Source-to-Pay and Enterprise Contract Lifecycle Management (ECLM) solutions. The Determine Cloud Platform provides procurement, legal and finance professionals analytics of their supplier, contract and financial performance. Our technologies empower customers to drive new revenue, identify savings, improve compliance and mitigate risk.

The Determine Cloud Platform seamlessly integrates with major ERP or third-party systems such as SAP, Oracle, Sage, QAD and Microsoft. Modular solutions can be configured to add more as needed to provide additional value beyond spend management. Our unified master database and business process approach empower users at every level to make more informed and smarter decisions.

For more information, please visit: www.determine.com.

Media Relations:

Mike MitchellDetermine Inc.+1.650.532.1590[email protected]

Determine, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended Twelve Months Ended
March 31, March 31,
2018 2017 2018 2017
Revenues:
Recurring revenues$ 5,467 $ 5,628 $ 21,864 $ 20,895
Non-recurring revenues 1,309 1,907 6,255 6,568
Total revenues 6,776 7,535 28,119 27,463
Cost of revenues:
Cost of recurring revenues 2,089 1,932 7,952 7,017
Cost of non-recurring revenues 1,343 1,630 5,546 6,608
Total cost of revenues 3,432 3,562 13,498 13,625
Gross profit:
Recurring gross profit 3,378 3,696 13,912 13,878
Non-recurring profit (loss) (34) 277 709 (40)
Total gross profit 3,344 3,973 14,621 13,838
Operating expenses:
Research and development 1,096 720 4,459 3,771
Sales and marketing 2,954 2,508 10,877 10,352
General and administrative 2,162 2,062 8,025 7,495
Total operating expenses 6,212 5,290 23,361 21,618
Loss from operations (2,868) (1,317) (8,740) (7,780)
Other expense, net (484) (477) (1,763) (1,865)
Net loss before income tax (3,352) (1,794) (10,503) (9,645)
Benefit from income taxes 530 86 555 229
Consolidated net loss (2,822) (1,708) (9,948) (9,416)
Net loss attributable to non-conrolling interest - - - (36)
Net loss attributable to common stockholders$ (2,822) $ (1,708) $ (9,948) $ (9,452)
Basic and diluted net loss per share$ (0.19) $ (0.14) $ (0.69) $ (0.81)
Determine, Inc.
GAAP to Non-GAAP Reconciliations
(In thousands)
(Unaudited)
Three Months Ended Twelve Months Ended
March 31, March 31,
2018 2017 2018 2017
Reconciliation of total revenue:
U.S. GAAP as reported$ 6,776 $ 7,535 $ 28,119 $ 27,463
Adjustments:
Deferred revenue adjustment - - - 8
Non-GAAP revenue$ 6,776 $ 7,535 $ 28,119 $ 27,471
Reconciliation of gross profit:
U.S. GAAP as reported$ 3,344 $ 3,973 $ 14,621 $ 13,838
Adjustments:
Deferred revenue adjustment - - - 8
Amortizaton of acquisition 260 249 1,028 1,007
Stock based compensation 22 74 166 314
Severance 0 1 82 25
Non-GAAP gross profit$ 3,626 $ 4,297 $ 15,897 $ 15,192
Reconciliation to non-GAAP net loss:
Net loss attributable to Determine, Inc.$ (2,822) $ (1,708) $ (9,948) $ (9,452)
Stock-based compensation expense 512 741 2,161 2,609
Deferred revenue adjustment - - - 8
Amortization on intangibles 548 525 2,161 2,119
Benefit for income taxes - - - (13)
Severance costs 36 14 139 48
Non-GAAP net loss$ (1,726) $ (428) $ (5,487) $ (4,681)
Non-GAAP basic and diluted net loss per share$ (0.12) $ (0.04) $ (0.38) $ (0.40)
Weighted average shares outstanding for basic
and diluted net loss per share 14,990 11,964 14,408 11,644
Determine, Inc.
Condensed Consolidated Statements of Comprehensive Loss
(In thousands)
(Unaudited)
Three Months Ended Twelve Months Ended
March 31, March 31,
2018 2017 2018 2017
Consolidated net loss$ (2,822) $ (1,708) $ (9,948) $ (9,416)
Foreign currency translation adjustments, net 281 (17) 1,309 (64)
Other comprehensive income (17) - (97) -
Comprehensive loss (2,558) (1,725) (8,736) (9,480)
Less: Net loss attributable to non-controlling interest - - - (36)
Comprehensive loss attributable to Determine, Inc.$ (2,558) $ (1,725) $ (8,736) $ (9,516)
Determine, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
March 31, March 31,
2018 2017
(Unaudited) (Audited)
ASSETS
Current assets
Cash and cash equivalents$ 9,928 $ 9,429
Accounts receivable, net 6,605 7,042
Restricted cash 28 34
Prepaid expenses and other current assets 1,542 1,553
Total current assets 18,103 18,058
Property and equipment, net 90 85
Capitalized software development costs, net 2,994 2,341
Goodwill 15,458 14,448
Other intangibles, net 3,952 5,860
Other assets 1,467 1,599
Total assets$ 42,064 $ 42,391
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Credit facility$ 12,128 $ 11,861
Accounts payable 2,371 2,478
Accrued payroll and related liabilities 1,986 1,729
Other accrued liabilities 2,239 2,042
Deferred revenue 9,487 10,070
Income tax payable 48 23
COFACE loan - 174
Total current liabilities 28,259 28,377
Long-term deferred revenue 84 10
Convertible note, net of debt discount 7,475 7,599
Other long-term liabilities 1,306 1,306
Total liabilities 37,124 37,292
Total stockholders' equity 4,940 5,099
Total liabilities and stockholders' equity$ 42,064 $ 42,391
Determine, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Twelve Months Ended
March 31, March 31,
2018 2017
Operating activities
Net loss $ (9,948) $ (9,416)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization 3,965 3,405
Loss on fixed asset disposal 2 -
Noncash income tax benefit (435) (208)
Interest expense paid in kind as convertible note debt 784 225
Stock-based compensation expense 2,161 2,609
Unrealized currency translation gains (41) -
Changes in assets and liabilities:
Accounts receivable, net 437 (11)
Prepaid expenses and other current assets (13) 3
Other assets 725 212
Accounts payable (112) 505
Accrued payroll and related liabilities 257 74
Accrued restructuring costs - (403)
Other accrued liabilities and other long-term liabilities 410 (65)
Deferred revenue (509) (286)
Net cash used in operating activities (2,317) (3,356)
Investing activities
Purchase of property and equipment (48) (57)
Capitalized software development costs, net (2,382) (1,829)
Net cash used in investing activities (2,430) (1,886)
Financing activities
Proceeds from issuance of stock, net of issuance costs 4,909 -
Net employee withholding taxes paid in connection to issuance of restricted stock (41) (132)
Issuance of stock under employee stock purchase plan 187 140
Credit facility borrowing 42,489 4,000
Credit facility payment (42,223) (1,139)
Repayment of loan (174) (233)
Proceeds from exercise of stock options 6 -
Issuance of convertible note, net of debt issuance costs - 2,429
Net cash provided by financing activities 5,153 5,065
Effect of exchange rate changes on cash 93 188
Net increase (decrease) in cash and cash equivalents 499 11
Cash and cash equivalents at beginning of the period 9,429 9,418
Cash and cash equivalents at end of the period$ 9,928 $ 9,429
Determine, Inc.
Billings Reconciliation
(In thousands)
(Unaudited)
Three Months Ended Twelve Months Ended
March 31, March 31,
2018 2017 2018 2017
Total revenues$ 6,776 $ 7,535 $ 28,119 $ 27,463
Deferred revenue:
End of period 9,571 10,080 9,571 10,080
Beginning of period 10,356 10,033 10,080 10,366
Change in deferred revenue (785) 47 (509) (286)
Total billings (total revenues plus the change in deferred revenue)$ 5,991 $ 7,582 $ 27,610 $ 27,177
Determine, Inc.
Non-GAAP EBITDA Reconciliation
(In thousands)
(Unaudited)
Three Months Ended Twelve Months Ended
March 31, March 31,
2018 2017 2018 2017
Reconciliation to non-GAAP EBITDA net loss:
Non-GAAP net loss$ (1,726) $ (428) $ (5,487) $ (4,681)
Interest 473 472 1,774 1,771
Depreciation 527 379 1,771 1,295
Income taxes and minority shareholder (530) (86) (555) (193)
Non-GAAP EBITDA net loss$ (1,256) $ 337 $ (2,497) $ (1,808)

Primary Logo

Source: Determine, Inc.

Categories

Press Releases